We provide you with 20 years of free, institutional-grade data for VTVT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VTVT. Explore the full financial landscape of VTVT stock.
| Reported Date | CIK | Ticker | Type |
|---|
vTv Therapeutics Inc(NASDAQ:VTVT) 
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates to fill unmet medical needs. The company is developing TTP399, an orally administered, small molecule, liver-selective glucokinase activator for the tr...
Website: http://www.vtvtherapeutics.com
Founded: 2015
Full Time Employees: 26
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about VTVT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.